COL7A1 gene — Drug Target
All drugs that target COL7A1 gene — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 3 pipeline (1)
- KB803 · Krystal Biotech, Inc. · Gene therapy · Dermatology / Rare Genetic Disorders
KB803 is a gene therapy that delivers a functional COL7A1 gene to restore type VII collagen production in patients with recessive dystrophic epidermolysis bullosa.